Orofacial Neuropathy Treatment

Orofacial neuropathy treatment encompasses clinical strategies for reducing pain and sensory dysfunction caused by injury, compression, inflammation, or disease affecting cranial sensory nerves, especially the trigeminal system. It matters because these disorders can impair eating, speaking, sleep, and quality of life. Treatment works by addressing the underlying cause and modulating abnormal nerve excitability and pain signaling in peripheral and central pathways. Depending on the diagnosis, care may combine medications, local injections or nerve blocks, surgery, neuromodulation, and rehabilitation to restore function and limit persistent pain. In neuroscience, studying treatment responses clarifies sensory-processing mechanisms and supports more precise approaches for traumatic, inflammatory, or idiopathic orofacial neuropathies.

Orofacial Neuropathy Treatment - Related Videos

Research

JoVE EoE - Neuropathology

Inducing Orofacial Neuropathic Pain in a Rat Model via Infraorbital Nerve Ligations

0 Views •

2025

This video demonstrates the induction of orofacial neuropathic pain in a rat model by ligating the infraorbital nerve. This results in nerve damage and inflammation, causing abnormal pain signaling and mimicking chronic pain conditions, which can be used to study the orofacial pain assay.

Nerve Ultrasound Protocol to Detect Dysimmune Neuropathies

0 Views •

Cited by 4 •

2021

This article presents a protocol for nerve ultrasound in polyneuropathies to aid the diagnosis of inflammatory neuropathies.

Rat Model of Photochemically-Induced Posterior Ischemic Optic Neuropathy

0 Views •

Cited by 2 •

2015

The goal of this protocol is to photochemically induce ischemic injury to the posterior optic nerve in rat. This model is critical to studies of the pathophysiology of posterior ischemic optic neuropathy, and therapeutic approaches for this and other optic neuropathies, as well as of other CNS ischemic diseases.

Research

JoVE Journal - Behavior
Free Sample

Use of the Operant Orofacial Pain Assessment Device (OPAD) to Measure Changes in Nociceptive Behavior

0 Views •

Cited by 42 •

2013

We present a user-friendly, high-throughput operant system for the evaluation of pain behaviors in awake, conscious rodents. The Orofacial Pain Assessment Device (OPAD) can assess pain through a reward/conflict paradigm thus providing a more humane way of testing. This protocol will yield more clinically relevant and translational data from rodents.

Establishing a Mouse Model of Small Fiber Neuropathy Using Resiniferatoxin

0 Views •

2025

This video demonstrates a method for establishing a small fiber neuropathy model in mice using the TRPV1 agonist resiniferatoxin (RTX). It outlines the steps involved in administering RTX to mice and explains how RTX induces neuronal death in small-diameter sensory neurons, thereby establishing the neuropathy model.

View All Results

FAQs

Related Topics